Z-1615-2023 Class III Ongoing

Recalled by Olympus Corporation Of The Americas — Center Valley, PA

FDA device recall Z-1615-2023 was initiated by Olympus Corporation Of The Americas on Mar 31, 2023 and is designated Class III. Reason for recall: Product non-conformance pertaining to the angle of the needle does not meet manufacturing specifications and remained unbent, resulting to slight resistance experienced during needle advancement and… The recall status is ongoing. Affected quantity: 2058 (Boxes; 5 per Box).

Recall details

Product Type
Devices
Report Date
May 31, 2023
Initiation Date
Mar 31, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2058 (Boxes; 5 per Box)

Product description

ViziShot 2 Single Use Aspiration Needle, 21G- To be used with ultrasound endoscopes for ultrasound guided fine needle aspiration (FNA) of submucosal and extramural lesions of the tracheobronchial tree and the gastrointestinal tract. Model: NA-U401SX-4021, NA-U401SX-4021-A

Reason for recall

Product non-conformance pertaining to the angle of the needle does not meet manufacturing specifications and remained unbent, resulting to slight resistance experienced during needle advancement and retraction.

Distribution pattern

Natiowide Foreign: Canada, Germany

Code information

UDI: 04953170388248 Lot numbers: KR243729 KR248648 KR248652 KR248673 KR248784 KR248785 KR248808 KR249160 KR251593 KR257313 KR257314 KR264662 KR264697 KR264708 KR264711 KR264726 KR264732 KR264746 KR264751 KR264778 KR264806 KR276770

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1615-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1615-2023. Report a data issue: hello@regdatalab.com.